Lawrence Otto Klein, Chief Executive Officer at Oruka Therapeutics, Inc. (ORKA), sold 25,000 shares at $83.40 ($2.1M) on 2026-10-01, disclosed to the SEC on 2026-10-02.
Scheduled sale ($2.1M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $83.40 | 16,246 | $1.4M | 64.8% |
| 2 | $84.03 | 8,554 | $719K | 34.4% |
| 3 | $84.78 | 200 | $17K | 0.8% |
| Total | $83.62 avg | 25,000 | $2.1M | 100% |
| Filing → |
| ORKA | SELL | 2026-06-15 | $120K | — | Filing → |
| ORKA | SELL | 2026-03-17 | $71K | — | Filing → |
| CRSP | SELL | 2021-03-25 | $24.1M | — | Filing → |